GO:0051298 centrosome duplication: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0051298 (centrosome duplication) describes the replication of a centrosome, a structure comprised of a pair of centrioles and peri-centriolar material from which a microtubule spindle apparatus is organized.
• Centrosome duplication is tightly coordinated with the cell cycle and is licensed so that each centrosome duplicates once, and only once, per cycle.
• The process begins with centriole disengagement and procentriole assembly, followed by elongation, maturation, and centrosome separation.
• Key regulators include PLK4, STIL, SAS-6, CEP152, CEP192, CPAP, and licensing factors such as nucleophosmin (NPM1) and CDK2-cyclin E.
• Deregulated centrosome duplication leads to centrosome amplification, which is observed in many cancers and is linked to chromosomal instability.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal testing of centrosome duplication genes in human cells.
Description
Centrosome duplication (GO:0051298) is the biological process by which a cell replicates its centrosome, the major microtubule-organizing center that comprises a pair of centrioles embedded in pericentriolar material. This process is essential for the formation of a bipolar mitotic spindle and for accurate chromosome segregation. Because the centrosome must be duplicated exactly once per cell cycle, its replication is subject to strict temporal and numerical control, often described as a licensing mechanism. Defects in centrosome duplication can produce extra centrosomes, which in turn can drive multipolar spindles, chromosome missegregation, and aneuploidy. For researchers, GO:0051298 provides a defined framework for studying the molecular machinery, regulatory checkpoints, and disease connections of centrosome replication. The term encompasses centriole disengagement, procentriole formation, elongation, maturation, and centrosome separation, integrating structural and regulatory events across the cell cycle. Understanding this process is therefore central to cell biology, cancer research, and the development of targeted experimental models.
centrosome duplication At A Glance
| GO ID | GO:0051298 |
|---|---|
| GO term | centrosome duplication |
| Ontology | biological_process |
| Synonym | centrosome replication |
| Major function | Replication of the centrosome, including centriole duplication and pericentriolar material assembly, to support bipolar spindle formation |
| Cell cycle timing | Occurs once per cell cycle, typically initiated near the G1/S transition and completed before mitosis |
| Key regulators | PLK4, STIL, SAS-6, CEP152, CEP192, CPAP, CDK2-cyclin E, NPM1 |
| Disease relevance | Centrosome amplification and duplication errors are linked to cancer and chromosomal instability |
What Is GO:0051298?
GO:0051298 (centrosome duplication) is defined as the replication of a centrosome, a structure comprised of a pair of centrioles and peri-centriolar material from which a microtubule spindle apparatus is organized. In other words, it is the process by which a cell copies its centrosome so that each daughter cell receives one. The synonym centrosome replication is also used. This process includes the duplication of centrioles and the coordinated assembly of pericentriolar material, ensuring that the centrosome can function as a microtubule-organizing center during mitosis.
Why Is centrosome duplication Important in Cell Biology?
Centrosome duplication is fundamental to genome stability because it ensures that each dividing cell has the correct number of centrosomes to build a bipolar spindle. When this process is deregulated, cells can acquire extra centrosomes, leading to multipolar divisions, aneuploidy, and tumorigenesis. Moreover, the machinery of centrosome duplication is increasingly recognized as a target for cancer therapy and as a source of biomarkers. Studying GO:0051298 therefore provides mechanistic insight into cell division, developmental disorders, and cancer biology.
• Ensures exactly one centrosome duplication per cell cycle, preventing centrosome amplification.
• Required for bipolar spindle assembly and accurate chromosome segregation.
• Deregulation causes multipolar spindles and aneuploidy, hallmarks of cancer.
• Centrosome amplification is observed in many solid tumors and hematological malignancies.
• Key regulators such as PLK4 and STIL are potential therapeutic targets.
• Licensing factors like NPM1 and CDK2-cyclin E control the initiation of duplication.
• Defects in centriole duplication are linked to developmental disorders such as microcephaly.
• Experimental models using CRISPR enable functional dissection of duplication genes.
• Centrosome duplication is coupled to the DNA replication cycle, integrating cell cycle checkpoints.
• Understanding this process aids in interpreting genomic instability in cancer research.
What Happens During centrosome duplication?
Centriole disengagement and licensing
In simple terms: Before a new centriole can form, the old centrioles must separate and the centrosome must be licensed for duplication.
Centrosome duplication begins with centriole disengagement, a process that separates the mother and daughter centrioles and is required for licensing the next round of duplication. Licensing ensures that each centrosome duplicates only once per cell cycle, and factors such as nucleophosmin (NPM1) and CDK2-cyclin E activity are implicated in this control. Disengagement is tightly regulated and involves proteolytic and phosphorylation events that prepare the centrosome for procentriole assembly.
Procentriole assembly and elongation
In simple terms: A new centriole starts to form next to each existing centriole and then grows longer.
Following licensing, procentriole assembly is initiated by the recruitment of PLK4, STIL, and SAS-6 to the cartwheel structure, which templates the ninefold symmetry of the centriole. CEP152 and CEP192 help localize PLK4 to the right place, and CPAP is required for centriole elongation. The procentriole then elongates through the addition of centriolar proteins, a step that is coordinated with the cell cycle.
Centrosome maturation and separation
In simple terms: The duplicated centrosomes mature and move apart to form the two poles of the mitotic spindle.
After duplication, the centrosomes undergo maturation, which involves the accumulation of pericentriolar material and increased microtubule-nucleating capacity. The two centrosomes then separate and migrate to opposite sides of the nucleus, a process that requires motor proteins and is essential for bipolar spindle formation. Errors in maturation or separation can lead to spindle defects and chromosome missegregation.
Coordination with the cell cycle
In simple terms: Centrosome duplication is timed to match the DNA replication cycle so that the cell has two centrosomes before it divides.
Centrosome duplication is coordinated with the cell cycle, typically beginning near the G1/S transition and completing before mitosis. This coordination involves cyclin-dependent kinases and checkpoint controls that prevent re-duplication within the same cycle. The tight coupling ensures that the centrosome cycle and the chromosome cycle remain in step, preserving genomic stability.
Key Genes Involved in GO:0051298 centrosome duplication
The following genes and proteins are central to centrosome duplication (GO:0051298) and are frequently studied in functional experiments.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PLK4 | Master kinase that initiates procentriole assembly | Key target for centrosome amplification studies |
| STIL | Cartwheel component required for procentriole formation | Essential for centriole duplication |
| SAS-6 | Cartwheel protein that establishes ninefold symmetry | Core structural component |
| CEP152 | Recruits PLK4 to the centriole | Regulator of duplication initiation |
| CEP192 | Scaffold for PLK4 and pericentriolar material | Important for centrosome maturation |
| CPAP | Centriole elongation factor | Required for centriole length control |
| NPM1 | Licensing factor for centrosome duplication | Links ribosome biogenesis to centrosome control |
| CDK2 | Cyclin-dependent kinase that promotes duplication | Cell cycle regulator of duplication |
| CCDC102A | Governs centrosome duplication and cohesion | Novel regulator with dual roles |
| ATAD5 | Suppresses centrosome over-duplication | Regulates UAF1 and ID1 |
| UAF1 | Deubiquitinase complex component | Modulates centrosome duplication |
| ID1 | Inhibitor of DNA binding, regulated by ATAD5 | Linked to centrosome over-duplication |
| CEP63 | Centriolar protein involved in duplication | Associated with microcephaly |
| CEP135 | Centriole assembly factor | Required for centriole biogenesis |
| SASS6 | Human SAS-6 homolog | Structural role in centriole duplication |
| PLK1 | Mitotic kinase that promotes centrosome maturation | Regulates separation and maturation |
| Aurora A | Kinase that regulates centrosome maturation and separation | Key mitotic regulator |
How Is centrosome duplication Regulated?
Centrosome duplication is regulated by cell cycle-dependent kinases, most notably CDK2-cyclin E and PLK4, which control the initiation and progression of centriole duplication. Licensing factors such as NPM1 and the ATAD5-UAF1-ID1 axis restrain over-duplication, ensuring that the process occurs only once per cycle. Additional regulation comes from checkpoint pathways that monitor centrosome number and integrity, and from proteolytic events that control centriole disengagement. The coordination between centrosome duplication and DNA replication is mediated by shared cell cycle regulators, which helps maintain genomic stability.
centrosome duplication and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PLK4 | Centrosome amplification in cancer | Overexpression and point-mutation models |
| NPM1 | Leukemia and centrosome over-duplication | Knockout and knock-in models |
| ATAD5 | Cancer predisposition and centrosome over-duplication | Knockout models |
| CEP63 | Microcephaly and Seckel syndrome | Point-mutation knock-in models |
| CCDC102A | Centrosome duplication and cohesion defects | Knockout and overexpression models |
Cancer and chromosomal instability
Centrosome amplification, often arising from deregulated duplication, is a common feature of many cancers and is associated with chromosomal instability and tumor progression. Overexpression of PLK4 or loss of licensing factors such as NPM1 can drive extra centrosomes, leading to multipolar spindles and aneuploidy. Targeting the centrosome duplication machinery is therefore an active area of cancer therapeutic research.
Developmental disorders
Mutations in genes required for centriole duplication, such as CEP63 and CPAP, are linked to developmental disorders including microcephaly and Seckel syndrome. These conditions highlight the importance of precise centrosome duplication for tissue development and brain size.
Other diseases
Dysregulation of centrosome duplication has also been implicated in ciliopathies and in some cases of infertility, although the mechanistic links are still being defined. The ATAD5-UAF1-ID1 pathway has been shown to suppress centrosome over-duplication, suggesting that its disruption may contribute to disease.
From centrosome duplication-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene cause centrosome amplification? | CRISPR knockout in human cell lines |
| Does a specific mutation affect PLK4 kinase activity? | Point-mutation knock-in |
| How does a disease-associated variant affect duplication? | Knock-in of the variant |
| Where does a protein localize during duplication? | Tagged knock-in (e.g., GFP) |
| Does overexpression drive over-duplication? | Inducible overexpression |
| What is the effect on cell cycle progression? | Knockout combined with live imaging |
How to Study the centrosome duplication Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescence microscopy | Centrosome number and duplication status | Screening for duplication defects |
| Live-cell imaging | Dynamics of centriole duplication | Real-time analysis |
| RNA-seq | Transcriptional changes upon perturbation | Pathway discovery |
| CRISPR library screening | Genes affecting centrosome duplication | Functional genomics |
| Proteomics | Protein interactions and complexes | Mechanistic studies |
| Kinase assay | PLK4 activity | Drug target validation |
| Cell cycle synchronization | Stage-specific effects | Temporal analysis |
Imaging-based assays
Fluorescence microscopy of centriolar markers such as CPAP, CEP152, and SAS-6 allows direct visualization of duplication events and centrosome number. Live-cell imaging with tagged proteins can track duplication dynamics in real time.
Genomic and transcriptomic profiling
RNA-seq and CRISPR library screening can identify genes that regulate centrosome duplication when knocked out or overexpressed. These approaches are useful for discovering novel regulators and for pathway analysis.
Proteomic and biochemical assays
Proteomics and co-immunoprecipitation can define the protein complexes involved in duplication, such as PLK4-STIL-CEP152 interactions. Kinase assays measure the activity of PLK4 and other regulators.
Functional perturbation
CRISPR knockout, point mutation, and overexpression models enable causal testing of gene function in centrosome duplication. These models can be combined with cell cycle synchronization to study stage-specific roles.
How CRISPR Can Be Used to Study GO:0051298 centrosome duplication
Knockout
CRISPR knockout of genes such as ATAD5 or CCDC102A can reveal their role in suppressing centrosome over-duplication. Knockout models are useful for loss-of-function studies and for identifying essential regulators.
Point Mutation
Point-mutation knock-in can model disease-associated variants in genes like PLK4 or CEP63, allowing assessment of their impact on centrosome duplication. This approach helps distinguish catalytic and non-catalytic functions.
Knock-in
Tagged knock-in of centriolar proteins (e.g., GFP-CPAP) enables visualization of duplication dynamics and protein localization. Knock-in of reporter cassettes can also be used to monitor pathway activity.
Overexpression
Overexpression of PLK4 or other regulators can induce centrosome amplification, providing a model for cancer-associated phenotypes. Inducible systems allow controlled timing of overexpression.
How EDITGENE Supports centrosome duplication Research
Researchers studying centrosome duplication-related genes often need to determine whether a candidate gene is causally involved in the process or is merely correlated with it. This requires precise genetic models that can knock out, mutate, tag, or overexpress the gene of interest in a controlled manner. EDITGENE provides such services to accelerate functional validation in centrosome biology.
Contact EDITGENE today to design your custom CRISPR model for centrosome duplication research.
Frequently Asked Questions About centrosome duplication
What is centrosome duplication?
Centrosome duplication (GO:0051298) is the process by which a cell replicates its centrosome, a structure made of a pair of centrioles and pericentriolar material, to support bipolar spindle formation.
What genes are involved in centrosome duplication?
Key genes include PLK4, STIL, SAS-6, CEP152, CEP192, CPAP, NPM1, CDK2, CCDC102A, and ATAD5.
Why is centrosome duplication important?
It ensures that each daughter cell receives one centrosome, which is essential for accurate chromosome segregation and genome stability.
What happens if centrosome duplication goes wrong?
Errors can lead to centrosome amplification, multipolar spindles, aneuploidy, and cancer.
How is centrosome duplication regulated?
It is regulated by cell cycle kinases such as CDK2-cyclin E and PLK4, and by licensing factors like NPM1 and the ATAD5-UAF1-ID1 axis.
What is the role of PLK4 in centrosome duplication?
PLK4 is a master kinase that initiates procentriole assembly and is essential for duplication.
How can I study centrosome duplication in the lab?
Common methods include fluorescence microscopy, live-cell imaging, RNA-seq, CRISPR screening, and proteomics.
What diseases are linked to centrosome duplication defects?
Cancer, microcephaly, Seckel syndrome, and some ciliopathies have been linked to defects in centrosome duplication.
What is the difference between centrosome duplication and centriole duplication?
Centrosome duplication encompasses the entire process of replicating the centrosome, including centriole duplication and pericentriolar material assembly.
Can CRISPR be used to study centrosome duplication?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect gene function in centrosome duplication.
Conclusion
Centrosome duplication (GO:0051298) is a tightly regulated process that ensures each cell has the correct number of centrosomes for accurate cell division. Its deregulation is linked to cancer and developmental disorders, making it a critical area of research. Advances in CRISPR-based models and screening technologies are accelerating the discovery of new regulators and therapeutic targets in this pathway.
References
- 1. Fu J et al.. 2015. The centrosome and its duplication cycle.. Cold Spring Harb Perspect Biol 7(2):a015800 PMID: 25646378
- 2. Wang T et al.. 2024. Dual roles of CCDC102A in governing centrosome duplication and cohesion.. Cell Rep 43(2):113696 PMID: 38280197
- 3. Nigg EA et al.. 2014. The centrosome duplication cycle in health and disease.. FEBS Lett 588(15):2366-72 PMID: 24951839
- 4. Okuda M. 2002. The role of nucleophosmin in centrosome duplication.. Oncogene 21(40):6170-4 PMID: 12214246
- 5. Kim SJ et al.. 2020. ATAD5 suppresses centrosome over-duplication by regulating UAF1 and ID1.. Cell Cycle 19(15):1952-1968 PMID: 32594826
- 6. Nigg EA. 2007. Centrosome duplication: of rules and licenses.. Trends Cell Biol 17(5):215-21 PMID: 17383880
- 8. Nigg EA et al.. 2011. The centrosome cycle: Centriole biogenesis, duplication and inherent asymmetries.. Nat Cell Biol 13(10):1154-60 PMID: 21968988
